Posted on 08/23/2021 2:44:54 PM PDT by ropin71
Alex Gorsky, who’s been J&J’s CEO since 2012, will hand the helm to company veteran and currently vice chairman of the executive committee, Joaquin Duato, effective Jan. 3, 2022, the company unveiled Thursday.
(Excerpt) Read more at fiercepharma.com ...
Sounds like it
I smell trouble.
Hmm, refused to take the vaccine?
He is 61 with an annual salary of $25M.
I could understand an earlier retirement if that is why he is leaving.
Pfizer won
Understood, but interesting timing.
All the Big Pharma execs are gonna have to run and hide before this is over—they know they are killing people...just waiting for the sheeple to figure it out...
Interesting timing.
My significant other has worked for the company over 25 years. She knows what he’s worth, but the timing has alarmed her. She also knows when a vaccine is being pushed way too soon, and we will not take it. She was advised last week that the company is mandating employees to be vaccinated. She works remotely, so we’ll see how it plays out.
You may be correct. My wife this morning got an email from the really big PPO on the west coast citing this problem.
That if she had possible problems associated with the powder, there were avenues to pursue.
Cash out those stock options baby.
It wasn’t all smooth sailing for Gorsky’s J&J.
The company is still navigating the high-profile talc lawsuits, which allege the baby powder caused ovarian cancer.
The company has also found itself embroiled in accusations that it played a part in the deadly opioid crisis. Last month, J&J and three largest drug distributors agreed to a $26 billion settlement to resolve thousands of opioid lawsuits with state attorneys.
RELATED: The top 10 pharma R&D budgets in 2020 | 3. Johnson & Johnson
J&J’s latest feats under Gorsky include the successful development of a single-shot COVID-19 vaccine. But that program has its own controversies.
U.S. authorities have warned of the shot’s increased risks of rare blood clots and the immune disorder Guillain-Barre syndrome. The side effects have stunted the vaccine’s sales growth momentum.
Millions of doses of the J&J vaccine were previously thrown out after the discovery of a major production misconduct at contract manufacturer Emergent BioSolutions. After the U.S. manufacturing fiasco, many shots of the vaccine that were bottled at a South African facility and originally meant for the region were instead sent to Europe, according to The New York Times. The move just sparked wide public criticism.
He is leaving due to a family health issue. Have some class and grace on here.
He’s helped create a lot of families health issues during his tenure. No quarter given.
Big Pharma Execs have led a vicious PR and political action (=bribery) campaign ramming their experimental vaccines down the throats of more than a billion people around the world.
They are unspeakably evil—totally off the charts.
Speaking the truth about raw evil is “class and grace”.
“He is 61 with an annual salary of $25M. I could understand an earlier retirement if that is why he is leaving.”
I think people in his shoes cannot fathom the idea of retiring and just playing golf (and trust me, you don’t make $25M without playing golf). He’s leaving for a reason, and we’ll probably find out soon enough.
I don’t think those working remotely should be forced. They don’t have face to face contact.
united states post office employees are exempt from vaccine mandates...
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.